glp-1 agonist and heart failure receptor agonists myocardial metabolism in atrial fibrillation Early trials of GLP-1 based
Description
What Else is New with GLP-1s While much of the news about health insurance coverage for GLP-1s is bad, there's good news too
has received consulting fees from Amgen, AstraZeneca Inc., Insulet, Kallyope and Pfizer Inc
Obesity can even shorten life expectancy by up to eight years and cut healthy life by up to 19 years
Clinical trial evidence consistently shows that GLP-1RA therapy results in significant reductions in fat mass, accompanied by smaller but measurable decreases in lean mass
Iglesias P, Bajo MA, Selgas R, Dez JJ
doi:10.1007/s12253-011-9404-9 91
